Back to search

Article

Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axis

2020-12-10

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Endometrial cancer is an invasive gynecological cancer prevalent in the world. The pathogenesis of endometrial cancer is related to multiple levels of regulation, referring to oestrogen, tumor-suppressor gene (e.g. PTEN ) or microRNAs (e.g. miR-23a and miR-29b). Metapristone is a hormone-related drug, which is widely used in clinical treatment of endometrial can...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
70b184aa-4a9d-54e8-ab84-2d7fae5b2a9e
DOI
10.21203/rs.2.23357/v5
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisDOI 10.21203/rs.2.23357/v5
Select a neighboring publication to make it the new centre.